Glass Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.35M Sell
2,685
-315
-11% -$151K 0.45% 41
2026
Q1
$1.47M Sell
3,000
-30
-1% -$16.3K 0.57% 41
2025
Q4
$1.76M Sell
3,030
-120
-4% -$67.9K 0.72% 39
2025
Q3
$1.53M Sell
3,150
-220
-7% -$102K 0.68% 41
2025
Q2
$1.37M Sell
3,370
-670
-17% -$280K 0.73% 42
2025
Q1
$2.01M Sell
4,040
-82
-2% -$44.4K 1.21% 32
2024
Q4
$2.14M Sell
4,122
-440
-10% -$242K 1.17% 32
2024
Q3
$2.82M Buy
4,562
+190
+4% +$112K 1.56% 26
2024
Q2
$2.42M Buy
4,372
+100
+2% +$57.3K 1.41% 29
2024
Q1
$2.48M Buy
+4,272
New +$2.4M 1.51% 30

Other funds holding TMO

Glass Wealth Management's TMO Position: Q2 2026 in Review

Glass Wealth Management reduced its Thermo Fisher Scientific (TMO) stake by 11% in Q2 2026, selling an estimated $151K and leaving 2,685 shares worth $1.35M. The position accounts for 0.45% of the portfolio, ranked #41.

Glass Wealth Management first reported a position in TMO in Q1 2024 and has held it in 10 quarters since. The position peaked at $2.82M in Q3 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Glass Wealth Management held 2,685 shares of Thermo Fisher Scientific worth $1.35M as of Q2 2026.
  • Glass Wealth Management sold 315 Thermo Fisher Scientific shares in Q2 2026, an estimated $151K.
  • Thermo Fisher Scientific made up 0.45% of Glass Wealth Management's portfolio in Q2 2026, its #41 holding.
  • Glass Wealth Management first reported a position in Thermo Fisher Scientific in Q1 2024 and has held it in 10 quarters since.
  • Glass Wealth Management's Thermo Fisher Scientific position peaked at $2.82M in Q3 2024.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Glass Wealth Management's 13F filing for Q2 2026, filed 30 Jul 2026.